Display options
Share it on

Indian J Nephrol. 2012 Jan;22(1):5-12. doi: 10.4103/0971-4065.91179.

Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus.

Indian journal of nephrology

S Torabinejad, R Mardani, Z Habibagahi, J Roozbeh, P Khajedehi, M Pakfetrat, M A Banihashemi, S J Banihashemi

Affiliations

  1. Shiraz Nephrology Urology Research Center, Zand Avenue, Shiraz, Iran.

PMID: 22279336 PMCID: PMC3263065 DOI: 10.4103/0971-4065.91179

Abstract

The purpose of this investigation was to assess the correlation of two biomarkers with the occurrence of renal flares in systemic lupus erythematosus (SLE). Urine levels of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor beta (TGF-β) were measured at baseline, and at two and four months in five groups of patients: 25 lupus nephritis patients with active disease (active LN), 10 lupus nephritis patients with SLE in remission (remission LN), 25 patients with clinical active SLE and without nephritis (active NLN), 10 patients without nephritis with SLE in remission (remission NLN) and 10 healthy controls. We used repeated measurement and ANOVA with Duncan's post hoc to analyze the data; the urine level of the two proteins could distinguish the groups based on the existence of lupus nephritis and/or activity of SLE disease. Furthermore we performed receiver operating curve analysis to identify a cutoff point with a good sensitivity and specificity to diagnose lupus nephritis with either one of the urine proteins. Finally the samples from active LN were grouped according to whether they were Class IV or other classes. Baseline urinary MCP-1, but not TGF-β, was significantly different between the classes. Further investigation into the use of these cytokines in a prospective study is needed to determine their capacity as diagnostic tools for renal flares.

Keywords: Lupus nephritis; monocyte chemotactic protein-1; systemic lupus erythematosus; transforming growth factor beta

References

  1. Lupus. 2006;15(12):845-51 - PubMed
  2. Arthritis Rheum. 2004 Sep;50(9):2882-90 - PubMed
  3. Am J Kidney Dis. 1982 Jul;2(1 Suppl 1):188-96 - PubMed
  4. Kidney Int. 2004 Feb;65(2):521-30 - PubMed
  5. Nephron Clin Pract. 2004;98(4):c105-11 - PubMed
  6. Kidney Int. 2008 Sep;74(6):799-807 - PubMed
  7. Arthritis Rheum. 1982 Nov;25(11):1271-7 - PubMed
  8. Kidney Int. 1996 Mar;49(3):761-7 - PubMed
  9. Lupus. 2002;11(2):95-101 - PubMed
  10. Autoimmun Rev. 2006 Jul;5(6):383-8 - PubMed
  11. Lupus. 2006;15(9):608-12 - PubMed
  12. Arthritis Rheum. 2009 Sep;60(9):2772-81 - PubMed
  13. Ann N Y Acad Sci. 2005 Jun;1051:421-32 - PubMed
  14. Semin Arthritis Rheum. 2010 Feb;39(4):257-68 - PubMed
  15. J Rheumatol. 2009 Jan;36(1):63-7 - PubMed
  16. Lab Invest. 1995 Dec;73(6):804-9 - PubMed
  17. J Am Soc Nephrol. 2000 Jan;11(1):152-176 - PubMed
  18. Ann Rheum Dis. 2007 Jul;66(7):886-92 - PubMed
  19. Medicine (Baltimore). 1993 Mar;72(2):113-24 - PubMed
  20. J Am Soc Nephrol. 2005 Feb;16(2):467-73 - PubMed
  21. Lupus. 2008 Jun;17(6):533-40 - PubMed
  22. Medicine (Baltimore). 2003 Sep;82(5):299-308 - PubMed
  23. Arthritis Rheum. 1998 May;41(5):778-99 - PubMed
  24. Am J Surg Pathol. 2006 Aug;30(8):1030-5 - PubMed
  25. Medicine (Baltimore). 2006 May;85(3):147-156 - PubMed
  26. Bull NYU Hosp Jt Dis. 2007;65(3):187-93 - PubMed
  27. Arthritis Rheum. 1992 Jun;35(6):630-40 - PubMed
  28. Arthritis Rheum. 2002 Apr;46(4):995-1002 - PubMed
  29. Kidney Int. 1996 Dec;50(6):2047-53 - PubMed
  30. Lupus. 1998;7(9):604-10 - PubMed
  31. Arthritis Rheum. 2007 Jun;56(6):2092-4 - PubMed
  32. J Am Soc Nephrol. 2004 Feb;15(2):241-50 - PubMed
  33. Lupus. 1998;7(9):611-7 - PubMed
  34. Transl Res. 2009 Jul;154(1):18-26 - PubMed
  35. Kidney Int. 2005 Oct;68(4):1825-33 - PubMed
  36. Arthritis Rheum. 2005 Dec;52(12):4003-10 - PubMed
  37. Nephrol Dial Transplant. 2006 Jun;21(6):1534-40 - PubMed

Publication Types